[1]樊茂蓉,徐凤芹△,王冰,等.补虚通痹方治疗特发性肺间质纤维化疗效观察[J].西部中医药,2019,32(05):77-80.
　FAN Maorong,XU Fengqin,et al.Observation on Clinical Effects of BuXu TongBi Prescriptions in the Treatment for Idiopathic Pulmonary Fibrosis[J].Western Journal of Traditional Chinese Medicine,2019,32(05):77-80.
点击复制

补虚通痹方治疗特发性肺间质纤维化疗效观察
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
32
期数:
2019年05期
页码:
77-80
栏目:
出版日期:
2019-05-15

文章信息/Info

Title:
Observation on Clinical Effects of BuXu TongBi Prescriptions in the Treatment for Idiopathic Pulmonary Fibrosis
文章编号:
1004-6852(2019)05-0077-04
作者:
樊茂蓉1，2，徐凤芹1△，王冰1，韩克华3，樊长征1，张琼1，苗青1
1 中国中医科学院西苑医院呼吸科，北京 100091； 2 北京中医药大学； 3 潍坊市中医院
Author(s):
FAN Maorong1, 2, XU Fengqin1△, WANG Bing1, HAN Kehua3, FAN Changzheng1, ZHANG Qiong1, MIAO Qing1
1 Department of Respiratory Medicine, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China; 2 Beijing University of Chinese Medicine; 3 Weifang City TCM Hospital
关键词:
特发性肺间质纤维化; 肺功能; 补虚通痹方
Keywords:
idiopathic pulmonary fibrosis;  pulmonary function;  BuXu TongBi prescriptions
分类号:
R563
摘要:
目的：观察补虚通痹方治疗特发性肺间质纤维化(idiopathic pulmonary fibrosis，IPF)的疗效及安全性。方法：将IPF患者60例随机分为对照组和观察组各30例，对照组采用大剂量N-乙酰半胱氨酸及按需氧疗治疗，观察组采用补虚通痹方加按需氧疗治疗，疗程3个月，随访3个月。比较2组患者治疗前后6分钟步行距离、生活质量、中医证候积分、呼吸困难及咳嗽单项症状积分、肺功能变化情况。结果：观察组在延长6分钟步行距离、改善患者呼吸困难及咳嗽症状方面优于对照组，并且观察组能够稳定患者肺功能，未发现严重不良反应。结论：补虚通痹方能提高IPF患者活动耐力、改善患者呼吸困难及咳嗽症状并稳定患者肺功能，且安全性好。
Abstract:
Objective: To observe clinical effects and the safety of BuXu TongBi prescription in the treatment for idiopathic pulmonary fibrosis (IPF). Methods: Sixty patients were randomized into the control group and the observation group, 30 cases each group, the control group adopted large dose of N acetylcysteine (NAC) and on-demand oxygen therapy, the observation group used BuXu TongBi prescription and on-demand oxygen therapy, the course was three months, they were followed for three months. To compare six-minutes walking distance, life quality, TCM syndrome scores, the scores of difficult breathing and single item of cough and the changes of pulmonary function between both groups. Results: Th observation group was superior to the control group in prolonging six minutes walking distance, improving dyspnea and cough, and the observation group could stabilize pulmonary function, and no severe adverse reaction happened. Conclusion: BuXu TongBi prescription could raise exercise endurance of IPF patients, improve dyspnea and cough, stabilize pulmonary function with good safety.

相似文献/References:

[1]王富国,张之舜,丁芬.中西医结合治疗慢性阻塞性肺疾病急性加重期28例疗效观察[J].西部中医药,2012,25(09):70.
　WANG Fu-guo,ZHANG Zhi-shun,DING Fen.Treating 28 Cases of Chronic Obstructive Pulmonary Disease at Acute Exacerbation with Integrated Traditional Chinese and Western Medicine[J].Western Journal of Traditional Chinese Medicine,2012,25(05):70.
[2]王兰娣,潘文.沙美特罗替卡松联合益气养阴合剂治疗轻症及缓解期COPD36例[J].西部中医药,2012,25(05):76.
　WANG Lan-di,PAN Wen.Treatment for 36 Cases of Chronic Obstructive Pulmonary Disease at Mild and Remission Stages with Salmeterol Fluticasone and Mixture of Replenishing Qi and Nourishing Yin[J].Western Journal of Traditional Chinese Medicine,2012,25(05):76.
[3]李涛,李小帆.补肺活血益肾汤联合艾灸对稳定期COPD患者肺功能及血液流变学的影响[J].西部中医药,2018,31(10):86.
　LI Tao,LI Xiaofan.Effects of Lung-tonifying Blood-activating Kidney-nourishing Decoction and Moxa-moxibustion on Pulmonary Function and Hemorheology of the Patients with Stable COPD[J].Western Journal of Traditional Chinese Medicine,2018,31(05):86.
[4]李桂荣,李晗怡△.冬病夏治穴位贴敷治疗儿童咳嗽变异性哮喘83例[J].西部中医药,2017,30(12):94.
　LI Guirong,LI Hanyi.Winter Disease Treated in Summer Acupoint Application in Treating 83 Children with Cough Variant Asthma[J].Western Journal of Traditional Chinese Medicine,2017,30(05):94.
[5]钱瑛,曹维宁,陈宏,等.纽曼自护理论模式应用于慢性阻塞性肺气肿患者的效果分析[J].西部中医药,2017,30(12):111.
　QIAN Ying,CAO Weining,CHEN Hong,et al.Analysis of the Effects of Neuman Self-care Theory Model Applied to the Patients with Chronic Obstructive Emphysema[J].Western Journal of Traditional Chinese Medicine,2017,30(05):111.
[6]主父瑶.河车虫草胶囊联合八段锦治疗慢性阻塞性肺疾病稳定期疗效观察[J].西部中医药,2018,31(03):89.
　ZHU Fuyao.Observation on Clinical Effects of HeChe ChongCao Capsules Combined with Eight-section Brocade in Treating Chronic Obstructive Pulmonary Disease at Stationary Phase[J].Western Journal of Traditional Chinese Medicine,2018,31(05):89.
[7]折哲,石克华△.复方佛耳草合剂对慢性阻塞性肺疾病急性加重患者气道炎症的影响[J].西部中医药,2018,31(09):5.
　ZHE Zhe,SHI Kehua.Effects of Compound FoErCao Mixture on Airway Inflammation of AECOPD Patients[J].Western Journal of Traditional Chinese Medicine,2018,31(05):5.
[8]惠朋利,李英,贺鹏.苏黄止咳胶囊联合噻托溴铵治疗慢性阻塞性肺疾病46例[J].西部中医药,2018,31(12):80.
　HUI Pengli,LI Ying,HE Peng.SuHuang Cough-stopping Capsules and Tiotropium Bromide in Treating 46 Cases of Chronic Obstructive Pulmonary Disease[J].Western Journal of Traditional Chinese Medicine,2018,31(05):80.
[9]瞿兴芹,周维华.认知行为疗法对肺源性心脏病患者心功能康复及焦虑、抑郁情绪的影响[J].西部中医药,2018,31(12):134.
　QU Xingqin,ZHOU Weihua.Effects of Cognitive Behavior Therapy on Cardiac Function Recovery,Anxiety and Depression of the Patients with Pulmonary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2018,31(05):134.
[10]季思勤,罗功汶,施克俭,等.六字诀干预慢性阻塞性肺疾病稳定期患者的临床研究[J].西部中医药,2019,32(04):111.
　JI Siqin,LUO Gongwen,SHI Kejian,et al.Clinical Study on Six-character Formula in the Intervention for COPD Patients at Stable Phase[J].Western Journal of Traditional Chinese Medicine,2019,32(05):111.

备注/Memo

备注/Memo:
收稿日期：2018-10-10 *基金项目：国家自然科学基金(编号81774297)；北京市自然科学基金(编号7126168)；北京市科学技术委员会课题(编号 Z131107002213053)。 作者简介：樊茂蓉(1974—)，女，博士学位，副主任医师。研究方向：呼吸疾病的中西医结合治疗。 △通讯作者：徐凤芹(1962—)，女，博士学位，主任医师。研究方向：老年病学。
更新日期/Last Update: 2019-05-15